NO20080104L - Inhibitorer av loselig adenylatsyklase - Google Patents

Inhibitorer av loselig adenylatsyklase

Info

Publication number
NO20080104L
NO20080104L NO20080104A NO20080104A NO20080104L NO 20080104 L NO20080104 L NO 20080104L NO 20080104 A NO20080104 A NO 20080104A NO 20080104 A NO20080104 A NO 20080104A NO 20080104 L NO20080104 L NO 20080104L
Authority
NO
Norway
Prior art keywords
adenylate cyclase
cyclase inhibitors
soluble adenylate
soluble
inhibitors
Prior art date
Application number
NO20080104A
Other languages
English (en)
Norwegian (no)
Inventor
Bernd Buchmann
Bernd Menzenbach
Duy Nguyen
Martin Fritsch
Ulf Boemer
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20080104L publication Critical patent/NO20080104L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20080104A 2005-06-08 2008-01-07 Inhibitorer av loselig adenylatsyklase NO20080104L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005027274A DE102005027274A1 (de) 2005-06-08 2005-06-08 Inhibitoren der löslichen Adenylatzyklase
PCT/EP2006/005608 WO2006131398A2 (fr) 2005-06-08 2006-06-07 Inhibiteurs de l'adenylate cyclase soluble

Publications (1)

Publication Number Publication Date
NO20080104L true NO20080104L (no) 2008-03-03

Family

ID=37398540

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080104A NO20080104L (no) 2005-06-08 2008-01-07 Inhibitorer av loselig adenylatsyklase

Country Status (23)

Country Link
EP (1) EP1888058B1 (fr)
JP (1) JP2008542422A (fr)
KR (1) KR20080016617A (fr)
CN (1) CN101193631A (fr)
AR (1) AR054378A1 (fr)
AT (1) ATE431736T1 (fr)
AU (1) AU2006256857A1 (fr)
BR (1) BRPI0610934A2 (fr)
CA (1) CA2606692A1 (fr)
CR (1) CR9578A (fr)
DE (2) DE102005027274A1 (fr)
DO (1) DOP2006000130A (fr)
EA (1) EA200702590A1 (fr)
EC (1) ECSP078024A (fr)
GT (1) GT200600244A (fr)
IL (1) IL186914A0 (fr)
MX (1) MX2007015493A (fr)
NO (1) NO20080104L (fr)
PE (1) PE20061488A1 (fr)
TW (1) TW200716090A (fr)
UY (1) UY29583A1 (fr)
WO (1) WO2006131398A2 (fr)
ZA (1) ZA200800153B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006014319B4 (de) * 2006-03-23 2009-01-08 Bayer Schering Pharma Aktiengesellschaft Inhibitoren der löslichen Adenylatzyklase
EP2036906A1 (fr) * 2007-09-05 2009-03-18 Bayer Schering Pharma Aktiengesellschaft Azaindoles en tant qu'inhibiteurs d'adénylatcyclase soluble

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635776B1 (fr) * 1988-09-01 1993-06-11 Rhone Poulenc Agrochimie Derives amides, procede pour leur fabrication et compositions fongicides les contenant
US20020064849A1 (en) * 2000-09-05 2002-05-30 Herr John C. Human soluble testicular adenylyl cyclase
IL158516A0 (en) * 2001-06-28 2004-05-12 Pfizer Prod Inc Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
KR20100107509A (ko) * 2001-09-14 2010-10-05 9222-9129 퀘벡 인코포레이티드 히스톤 데아세틸라아제의 억제제
UA79504C2 (en) * 2002-11-07 2007-06-25 Organon Nv Indols for treating diseases associated with androgen receptors
DE602004032446D1 (de) * 2003-08-07 2011-06-09 Rigel Pharmaceuticals Inc 2,4-pyrimidindiamin-verbindungen und verwendungen als antiproliferative mittel
EP1677731A4 (fr) * 2003-10-09 2009-05-06 Aton Pharma Inc Derives thiophene et benzothiophene d'acide hydroxamique
EP1706114B1 (fr) * 2004-01-21 2012-12-26 Cornell Research Foundation, Inc. Inhibiteurs chimiques d'adenylyle cyclase soluble (sac)
EP1735319B1 (fr) * 2004-03-26 2017-05-03 MethylGene Inc. Inhibiteurs d'histone desacetylase
DE102004047272A1 (de) * 2004-09-24 2006-04-06 Schering Ag Inhibitoren der löslichen Adenylatzyklase

Also Published As

Publication number Publication date
EA200702590A1 (ru) 2008-06-30
AU2006256857A1 (en) 2006-12-14
ECSP078024A (es) 2008-01-23
WO2006131398A2 (fr) 2006-12-14
PE20061488A1 (es) 2007-02-03
EP1888058A2 (fr) 2008-02-20
BRPI0610934A2 (pt) 2010-08-03
DE602006006908D1 (de) 2009-07-02
CN101193631A (zh) 2008-06-04
GT200600244A (es) 2007-01-23
ATE431736T1 (de) 2009-06-15
AR054378A1 (es) 2007-06-20
KR20080016617A (ko) 2008-02-21
MX2007015493A (es) 2008-02-22
UY29583A1 (es) 2007-01-31
CR9578A (es) 2008-03-06
WO2006131398A3 (fr) 2007-04-19
EP1888058B1 (fr) 2009-05-20
TW200716090A (en) 2007-05-01
DE102005027274A1 (de) 2006-12-14
IL186914A0 (en) 2008-02-09
ZA200800153B (en) 2009-03-25
JP2008542422A (ja) 2008-11-27
CA2606692A1 (fr) 2006-12-14
DOP2006000130A (es) 2006-11-30

Similar Documents

Publication Publication Date Title
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20090295L (no) Substituerte heteroarylderivater
NO20090628L (no) Pyridizinon derivativater
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
WO2005075425A3 (fr) Derives de bisaryluree
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
NO20071074L (no) Substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
NO20065946L (no) DPP-IV-inhibitorer
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
PL1899329T3 (pl) Pirymidyno-podstawione pochodne benzimidazolu jako inhibitory kinaz białkowych
NO20070089L (no) DPP-IV inhibitorer
EA200900135A1 (ru) Производные пиразола в качестве ингибиторов цитохрома р450
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
WO2007009724A3 (fr) Derives de pyrazoline substitues cycloalkane, fabrication et utilisation comme medicaments
NO20073631L (no) Metasubstituerte tiazolidinoner, fremgangsmate for fremstilling og anvendelse av disse som legemiddel
EA201001747A1 (ru) Бензоксазиноновые производные, действующие в качестве агониста бета-2-адренорецептора, для лечения респираторных расстройств
MY150098A (en) Benzylpiperazine derivates and their medical use
NO20072078L (no) Indolderivater som inhibitorer av loselig adenylsyklase
UA106200C2 (uk) Заміщені похідні оксіндолу та їхнє застосування для лікування захворювань, залежних від вазопресину
IL191670A0 (en) Compounds for the inhibition of apoptosis
NO20080104L (no) Inhibitorer av loselig adenylatsyklase
NO20083352L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
WO2007107385A3 (fr) Inhibiteurs de l'adénylate-cyclase soluble

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application